International Journal of

Virology and AIDSISSN: 2469-567X


 Open Access DOI:10.23937/2469-567X/1510076

A Review on Interventions against COVID-19

Sintayehu Tsegaye Tseha

Article Type: Review Article | First Published: September 24, 2021

COVID-19 remains the main public health problem in the world. The major objective of this review is to discuss interventions that have been employed against COVID-19. The preventive and control measures that have been employed against COVID-19 include: staying at home, social and physical distancing, quarantine, washing hand with sanitizer, using face mask, immunization, timely diagnosis and treatment of the disease. In spite of its high false negative rate, real time-PCR remains the gold standa...

 Open Access DOI:10.23937/2469-567X/1510075

Prevalence of, and Factors Influencing First Line Antiretroviral Treatment Failure among Adult HIV Patients at Antiretroviral Treatment Clinic of Mettu Karl Referral Hospital, South Western, Ethiopia: A Prospective Cross Sectional Study, 2021

Gudisa Bereda and Gemechis Bereda

Article Type: Research Article | First Published: July 28, 2021

Antiretroviral treatment failure is defined as progression of disease and high risk of mortality after beginning of highly active anti-retroviral therapy. First-line ART failure has emerged as a growing concern. ART failure is a major challenge to HIV/AIDS management in resource-limited settings including Ethiopia where the diagnosis and management of ART failure is a key problem. Principal factors involving fist-line antiretroviral regimen failure include poor adherence to medication, younger a...

 Open Access DOI:10.23937/2469-567X/1510074

Subclinical Iron Overload Hampers the Beneficial Effect of Human Pegivirus (Hpgv) On Disease Progression in Human Immunodeficiency Virus Type-1 Infected Blood Donors

Debasish Chattopadhya, Alice Verghese, Uma Sharma and Arvind Rai

Article Type: Researc h Article | First Published: March 31, 2021

A prospective study on HIV-1 disease progression was undertaken in three HIV-1 infected blood donor subgroups at early asymptomatic stages: Those with HPgV co-infections (n = 60), with TTV co-infections (n = 48) and without the two co-infections (n = 54). Within each subgroup, both replacement and voluntary donors are examined. The markers of HIV-1 disease progression included the following virological and immunological parameters: Rate of increase in plasma HIV-1 viral load, rate of fall in CD4...

 Open Access DOI:10.23937/2469-567X/1510073

Influenza A or COVID-19 Reinfection? Making the Right Diagnosis during the COVID-19 Pandemic

Njideka Udochi, MD, MPH, FAAFP, AAHIVS, Hazel Jones Parker, DNP, CRNP, AAHIVS and Melonie Owusu, BSN, RN

Article Type: Case Report | First Published: January 16, 2021

As the second wave of SARS-CoV-2 (COVID-19) rages through the Unites States (US), it is coinciding with Influenza season, both being spread via respiratory droplets. Influenza symptoms such as cough, myalgia, and fever mirror symptoms of COVID-19. Reinfection with the SARS-CoV-2 virus has been described but is relatively rare. Several studies have described patients with long periods of positivity after initial COVID-19 infections. Disrupted care during the COVID-19 pandemic may contribute to in...

Volume 8
Issue 1